arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL
$267.38 ▲ +1.68 (+0.63%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
19 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
39
Health
Weak
Bearish
auto_awesome

Analytical Summary

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $13.3B
Dividend Yield
Revenue Growth -0.9%
Op. Margin 0.6%
ROIC 1.1%
FCF / Share $14.88
Trailing P/E
Price / Book 4.2x
FCF Yield 5.6%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$4.02B
↓ -0.9%
Net Income Profit after all expenses
$-144.34M
↓ -750.1%
Operating Margin Operating profit as % of sales
0.6%
↓ -88.8% 30th
FCF / Share Free cash flow per share
$14.88
↑ +4.1%
Long-Term Debt Long-term obligations
$1.61B
↑ +48.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
45
Returns
39
Financial Health
50
Cash Quality
3

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters